Mr. Jonathan Chen is the Chief International Business Officer of the Company, Chairperson of ICC, Co-Chairperson of IOC, and a member of GMC.
Prior to current positions, he has served as the Executive Vice President of International Operations and Investor Relations of the Company. Mr. Chen's primary responsibilities include expanding the company's International business in markets of the U.S, Europe, Asia Pacific and South America. Mr. Chen has over 28 years of experience in the medical device industry.
Prior to joining the Company, Mr. Chen worked for Angiotech Pharmaceuticals, Inc. for 6 years, where he was Senior Vice President of Business Development & Financial Strategy. He led the management team to build a diversified medical products business through several transformational acquisitions and licensing transactions. Prior to joining Angiotech, Mr. Chen was a life sciences investment banker for Credit Suisse and Alex. Brown & Sons where he advised his clients on equity and debt capital raising as well as on Mergers & Acquisitions transactions.
Mr. Chen holds a Bachelor of Arts degree in Economics and a Bachelor of Sciences degree with honors in Biological Sciences from Stanford University.